Suppr超能文献

布雷菲德菌素A对大鼠软骨肉瘤细胞中聚集蛋白聚糖核心蛋白合成及成熟的影响。

Effects of brefeldin A on aggrecan core protein synthesis and maturation in rat chondrosarcoma cells.

作者信息

Calabro A, Hascall V C

机构信息

Proteoglycan Chemistry Section, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20892.

出版信息

J Biol Chem. 1994 Sep 9;269(36):22771-8.

PMID:8077229
Abstract

In this paper, the effects of the fungal metabolite, brefeldin A, on the synthesis and maturation of aggrecan core protein precursor were studied in rat chondrosarcoma chondrocytes. The aggrecan core protein precursor was partially identified in total protein pools isolated from cell extracts based on its selective cleavage at a single site by the restriction protease factor Xa. During a 2-h labeling period with [3H]serine as precursor, brefeldin A inhibited the synthesis of mature aggrecan from its aggrecan core protein precursor consistent with an inhibition of chondroitin sulfate chain elongation and sulfation as described in the accompanying paper (Calabro, A., and Hascall, V. C. (1994) J. Biol Chem. 269, 22764-22770). This inhibition is presumably the result of the disruption of vesicular transport by brefeldin A, which isolates the aggrecan core protein precursor at the level of the trans-Golgi cisternae from the enzymes for chondroitin sulfate chain elongation and sulfation located in the trans-Golgi network. Brefeldin A also inhibited the exocytosis of all radiolabeled secretory proteins from the cell layer into the medium compartment, which is also consistent with the disruption of vesicular transport attributed to this metabolite. Although total protein synthesis was inhibited by 12% in the presence of brefeldin A, the aggrecan core protein precursor accumulated within the cell layer indicating that the inhibition of chondroitin sulfate synthesis by brefeldin A was not the result of a lack of aggrecan core protein precursor. When the brefeldin A block was removed and cultures chased in the presence of cycloheximide to prevent new protein synthesis, vesicular transport through the cell was re-established and chondroitin sulfate chains were added to a large proportion of the aggrecan core protein precursor that had accumulated during the brefeldin A block. These results suggest that the machinery for chondroitin sulfate synthesis and for protein exocytosis, that were disrupted by brefeldin A treatment, recover after removal of the brefeldin A, even in the presence of cycloheximide, and that the structures involved in these processes reassemble from previously existing proteins. Interestingly, two other proteins with the same relative abundance as the aggrecan core protein precursor were observed. An approximately 210-kDa protein with the characteristics of the fibronectin subunit, and an unidentified approximately 150-kDa protein which was efficiently cleaved by the protease Xa enzyme.

摘要

在本文中,我们研究了真菌代谢产物布雷菲德菌素A对大鼠软骨肉瘤软骨细胞中聚集蛋白聚糖核心蛋白前体的合成和成熟的影响。基于其在单一位点被限制性蛋白酶因子Xa选择性切割,在从细胞提取物中分离的总蛋白库中部分鉴定出了聚集蛋白聚糖核心蛋白前体。在用[3H]丝氨酸作为前体的2小时标记期内,布雷菲德菌素A抑制了从其聚集蛋白聚糖核心蛋白前体合成成熟的聚集蛋白聚糖,这与随附论文中所述的硫酸软骨素链延伸和硫酸化的抑制一致(卡拉布罗,A.,和哈斯卡尔,V. C.(1994年)《生物化学杂志》269,22764 - 22770)。这种抑制可能是布雷菲德菌素A破坏囊泡运输的结果,它将聚集蛋白聚糖核心蛋白前体在反式高尔基体池水平与位于反式高尔基体网络中的硫酸软骨素链延伸和硫酸化酶隔离开来。布雷菲德菌素A还抑制了所有放射性标记的分泌蛋白从细胞层向培养基隔室的胞吐作用,这也与这种代谢产物导致的囊泡运输破坏一致。尽管在布雷菲德菌素A存在的情况下总蛋白合成被抑制了12%,但聚集蛋白聚糖核心蛋白前体在细胞层内积累,这表明布雷菲德菌素A对硫酸软骨素合成的抑制不是由于缺乏聚集蛋白聚糖核心蛋白前体。当去除布雷菲德菌素A的阻断并在存在环己酰亚胺以防止新蛋白合成的情况下对培养物进行追踪时,通过细胞的囊泡运输得以重新建立,并且硫酸软骨素链被添加到在布雷菲德菌素A阻断期间积累的大部分聚集蛋白聚糖核心蛋白前体上。这些结果表明,被布雷菲德菌素A处理破坏的硫酸软骨素合成和蛋白胞吐作用机制,在去除布雷菲德菌素A后即使在存在环己酰亚胺的情况下也能恢复,并且参与这些过程的结构是从先前存在的蛋白质重新组装而成的。有趣的是,观察到另外两种与聚集蛋白聚糖核心蛋白前体具有相同相对丰度的蛋白质。一种具有纤连蛋白亚基特征的约210 kDa的蛋白质,以及一种未鉴定的约150 kDa的蛋白质,它能被蛋白酶Xa酶有效切割。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验